UBS Group’s NuCana NCNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,653
| Closed | -$13.2K | – | 10943 |
|
|
2025
Q4 | $13.2K | Sell |
3,653
-6,598
| -64% | -$27.3K | ﹤0.01% | 8067 |
|
|
2025
Q3 | $47.6K | Buy |
+10,251
| New | +$65.6K | ﹤0.01% | 7594 |
|
|
2025
Q2 | – | Hold |
0
| – | – | – | 10645 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10144 |
|
|
2024
Q4 | – | Sell |
-63
| Closed | -$19.6K | – | 9823 |
|
|
2024
Q3 | $29K | Buy |
+63
| New | +$49K | ﹤0.01% | 7144 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 9329 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 8960 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 8930 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8908 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7901 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 9181 |
|
|
2022
Q4 | – | Hold |
0
| – | -$1K | – | 10998 |
|
|
2022
Q3 | – | Sell |
-2
| Closed | -$14.4K | – | 9991 |
|
|
2022
Q2 | $6K | Buy |
+2
| New | +$7.41K | ﹤0.01% | 8702 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | -$7K | – | 10672 |
|
|
2021
Q4 | $7K | Buy |
+1
| New | +$12.6K | ﹤0.01% | 9156 |
|
|
2021
Q1 | – | Hold |
0
| – | -$8K | – | 9311 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7629 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6773 |
|
|
2020
Q1 | – | Hold |
0
| – | -$3K | – | 8243 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7753 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7217 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6771 |
|
|
2019
Q1 | – | Hold |
0
| – | -$12K | – | 8004 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7143 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6082 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7557 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6151 |
|
Other funds holding NCNA
GJIA
VF
CIAM
UBS Group's NCNA Position: Q1 2026 in Review
UBS Group sold out of NuCana (NCNA) in Q1 2026, closing a stake of 3,653 shares — an estimated $13.2K sold.
UBS Group first reported a position in NCNA in Q4 2021 and held it in 5 quarters. The position peaked at $47.6K in Q3 2025. 8 funds tracked by Wall St. Rank hold NCNA as of Q1 2026.
- UBS Group reported no remaining NuCana position as of Q1 2026 after selling out during the quarter.
- UBS Group sold 3,653 NuCana shares in Q1 2026, an estimated $13.2K.
- UBS Group first reported a position in NuCana in Q4 2021 and held it in 5 quarters.
- UBS Group's NuCana position peaked at $47.6K in Q3 2025.
- 8 funds tracked by Wall St. Rank held NuCana as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.